The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...
Chronic hepatitis B (CHB) poses a major global health burden, with China particularly affected. Effective antiviral therapy ...
SNP genotyping is an exciting field. The completion of the human genome sequencing project has enabled SNP research to move forward. SNP genotyping allows for further characterization of the human ...
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for HER2-Amplified Advanced Biliary Tract Cancer Among 667 patients with both baseline ctDNA ...
Chronic hepatitis B (CHB) poses a major global health burden, with China particularly affected. Effective antiviral therapy is crucial to prevent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results